Magnesium Alloy Foams for Bioresorbable Bone Implants

A team of researchers from Poland and Germany has fabricated magnesium alloy foams for use in tissue engineering and producing bone implants that are bioresorbable. Their findings have been published in the Journal of Magnesium and Alloys.

Study: Development of open-porosity magnesium foam produced by investment casting. Image Credit: Mongkolchon Akesin/Shutterstock.com

Metal Foams

Metal foams are a highly interesting class of metallic materials, possessing unique properties that have made them the focus of research in several fields. Their main applications thus far have been in the aerospace and automotive industries, and they have also been researched for use as silencers, lightweight building materials, shock-absorbing materials, heat exchangers, and catalysts.

Metal foams possess highly porous structures, which has led to research interest for these materials for the biomedical industry, especially for innovative implants. Magnesium foams have shown particular promise for biomedical applications due to their superior biocompatibility.

Additionally, magnesium foams have similar mechanical properties and density to bone tissue, which gives them advantages over conventional implant materials such as titanium and steel. This property is important for implants as it decreases the stress experienced by the organic tissue, helping to aid bone growth.

Another advantage of magnesium is its biodegradability. This facilitates the development of short-term implants that require no further surgical intervention to remove, significantly reducing the stress faced by the patient. Whilst magnesium does possess low resistance to corrosion, the products of this corrosion are not harmful to the patient as they are non-toxic, soluble, and the body can get rid of them in urine.

However, whilst the products of magnesium corrosion themselves are not dangerous compared to conventional implant materials such as stainless steel and titanium, there are issues with the generation of localized hydrogen bubbles. This can lead to delayed healing due to tissue necrosis and tissue layer segregation.

Special coatings can extend the life of magnesium foam implants. Plasma electrolytic oxidation has proven particularly effective for this purpose. The space-holder method is the primary method for fabricating magnesium foams. Powder metallurgy and investment casting are also used.

The Study

The researchers behind the study published in the Journal of Magnesium and Alloys have presented a novel method based on investment casting for fabricating magnesium foams for use in bone implants. Their approach involves using a polyurethane foam pattern that is coated with wax slurry. This improves the material’s mechanical properties and increases its density.

Using the novel method, magnesium foams with a highly controlled morphology can be fabricated, which overcomes the drawbacks of the conventional salt particle space holder method. The method presented by the researchers uses readily available materials. Equipment used in this fabrication method is less specialized than other strategies for producing magnesium foams. The researchers used AZ91 alloy to cast the magnesium foams.

More from AZoM: What is Localization Atomic Force Microscopy?

To prepare the molds, they were subjected to heat treatment, which removed the polyurethane foam and left behind the pattern. The AZ91 alloy was then cast in a protective gas atmosphere at 660-680 oC. Calculations followed by experimental trials aided the selection of the molds and temperature for pouring the metal.

It was noted by the authors that multiple factors, including the vacuum system, influence the process conditions and outcomes. The temperature of the liquid metal and the mold, alongside the vacuum value, are the most important parameters which influence the penetration of cavities and minimize adverse reactions between metal and ceramic materials during the process.

A protective coating was applied to the material during pouring by feeding a mixture of CO2 and SF6 gas and precisely controlling the temperature parameters during both pouring and cooling stages. This was applied to prevent rupturing of the mold by the build-up of sulfur dioxide caused by the decomposition of calcium sulfate and accelerated oxidation.

Comprehensive testing on both uncoated magnesium foams and those treated with plasma electrolytic oxidation processing was carried out. Analysis of compression tests demonstrated that there was a correlation between the foam’s porosity and mechanical properties. An in-depth categorization of several properties of the foams was performed in the study, including a fractography analysis and an analysis of the material’s corrosive behavior.

The authors have stated that adding ceramic surface layers improves the foam’s degradation behavior, provides opportunities for adding surface functionality such as antimicrobial properties, and affects the mechanical properties of the prepared foams. However, the authors noted that their research is a feasibility study for exploring the conditions of applying surface coatings to magnesium foams. Further work will be needed to explore the optimization of the process to achieve a uniform coating using plasma electrolysis oxidation.

Several conclusions were drawn by the researchers. For instance, thin coatings do not achieve the desired mechanical functions, whereas thicker coatings do, but they are unpredictable and prone to fracturing. Furthermore, whilst using particles can add functionality, the effect of additional coatings on properties such as mechanical integrity, biocompatibility, and degradation behavior requires further studies to properly elucidate. However, their research has provided some pertinent pointers for future research on developing magnesium foams for use in bioresorbable bone implants.

Further Reading

Kapłona, H et al. (2022) Development of open-porosity magnesium foam produced by investment casting [online] Journal of Magnesium and Alloys 10(1) | sciencedirect.com. Available at: https://www.sciencedirect.com/science/article/pii/S2213956722000391

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Reginald Davey

Written by

Reginald Davey

Reg Davey is a freelance copywriter and editor based in Nottingham in the United Kingdom. Writing for AZoNetwork represents the coming together of various interests and fields he has been interested and involved in over the years, including Microbiology, Biomedical Sciences, and Environmental Science.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Davey, Reginald. (2022, March 24). Magnesium Alloy Foams for Bioresorbable Bone Implants. AZoM. Retrieved on April 27, 2024 from https://www.azom.com/news.aspx?newsID=58625.

  • MLA

    Davey, Reginald. "Magnesium Alloy Foams for Bioresorbable Bone Implants". AZoM. 27 April 2024. <https://www.azom.com/news.aspx?newsID=58625>.

  • Chicago

    Davey, Reginald. "Magnesium Alloy Foams for Bioresorbable Bone Implants". AZoM. https://www.azom.com/news.aspx?newsID=58625. (accessed April 27, 2024).

  • Harvard

    Davey, Reginald. 2022. Magnesium Alloy Foams for Bioresorbable Bone Implants. AZoM, viewed 27 April 2024, https://www.azom.com/news.aspx?newsID=58625.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.